The drug has been hailed as a breakthrough in managing the deadliest of all the major cancers. Source link : ...

Sudden cardiac death can happen without warning, and it's not just a problem for sporty young men, say experts. Source ...

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than ...

CHICAGO -- A paradigm-changing clinical trial in prostate cancer showed that perioperative apalutamide (Erleada) and androgen deprivation therapy (ADT) significantly ...

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced ...

"The light goes out of their eyes in about 3 years. This is not what they signed up for." -- ...

CHICAGO -- A first-in-class bispecific antibody targeting PD-1 and VEGF combined with chemotherapy significantly improved overall survival (OS) in patients ...

Donald Trump's physician says the president is in "excellent health" and is "fully fit" to serve as commander in chief ...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy. Medscape Medical News Source ...

CHICAGO -- Treatment with the CDK4/6 inhibitor abemaciclib (Verzenio) offered a dramatic survival uptick in a highly aggressive soft-tissue cancer ...

CHICAGO -- The adjuvant treatment of RET fusion-positive non-small-cell lung cancer (NSCLC) following potentially curative surgery or radiotherapy has a ...

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold. Medscape ...

Peptides have moved from bodybuilding forums into the cultural mainstream. Telehealth clinics advertise them for weight loss and recovery, often ...

CHICAGO -- Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with ...

Experts at the Primary Care Show identified the key barriers to lipid management — and what clinicians can do about ...

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo ...

CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase ...

Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS. Source link : https://www.bbc.com/news/articles/cd9p50j3ljko?at_medium=RSS&at_campaign=rss Author ...

CHICAGO -- Adding an investigational TROP2-targeted antibody-drug conjugate (ADC) to first-line immunotherapy for PD-L1-positive non-small cell lung cancer (NSCLC) reduced ...

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations. Medscape Medical News Source link : ...